• All sections
  • C - Chemistry; metallurgy
  • C07D - Heterocyclic compounds
  • C07D 251/18 - Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines

Patent holdings for IPC class C07D 251/18

Total number of patents in this class: 178

10-year publication summary

24
10
27
8
14
9
8
12
5
3
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Servier Pharmaceuticals, LLC
95
16
BASF SE
19740
14
Agios Pharmaceuticals, Inc
200
7
Emory University
1498
7
Anji Pharmaceuticals Inc.
38
7
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
616
6
Pfizer Inc.
3322
5
Centaurus Biopharma Co., Ltd.
84
5
Lianyungang Runzhong Pharmaceutical Co., Ltd.
85
5
Bayer Cropscience AG
2241
3
Takeda Pharmaceutical Company Limited
2961
3
Luoda Biosciences, Inc.
5
3
Minoryx Therapeutics S.L.
45
3
The United States Government AS represented by The Department of Veterans Affairs
949
3
University of Basel
39
3
Aluda Pharmaceuticals, Inc.
3
3
Centre National de La Recherche Scientifique
9632
2
Astellas Pharma Inc.
1145
2
Betta Pharmaceuticals Co., Ltd.
161
2
Borealis Agrolinz Melamine GmbH
24
2
Other owners 77